Edmonton, Alberta, Canada
June 30, 2010
Innovotech Inc. (TSX VENTURE:IOT), a pioneer in the field of biofilm product development, has secured funding in excess of $900,000 from Agriculture and Agri-Food Canada to facilitate the commercialization of Agress(TM), its unique, environmentally friendly seed treatment and plant spray designed to protect crops against both bacterial and fungal infections.
"With the potential to increase crop yields and improve product quality while minimizing the risk of antibacterial resistance, Agress(TM) has the opportunity to provide a cost-effective solution for the Agricultural Industry where current technologies either have undesirable effects on the environment or do not work well," said Ken Boutilier, President and CEO of Innovotech Inc.
The two year, repayable funding, administered in Alberta through the Agriculture and Food Council, will focus on field trials to expand the potential applications of Agress(TM) from pulse crops (dry beans, dry peas, lentils, chickpeas) and soybeans to high value horticultural crops such as tomatoes, peppers, and potatoes. The funding will also be used to support regulatory approval submissions for Agress(TM).
Innovotech Inc. is a pioneer in the field of biofilm product development, focused on providing innovative and practical solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are responsible for a host of diseases both in agriculture and human health due to their inherent resistance to existing antibiotics and disinfectants. There are currently no antibiotics, disinfectants, diagnostics or regulatory standards designed specifically for biofilm-forming organisms.
Innovotech currently has two products in advanced stages of development: Agress(TM) a unique, environmentally friendly seed treatment and plant spray designed to protect crops against both bacterial and fungal infections, and bioFILM PA(TM), the first diagnostic kit to assist physicians in the selection of the most effective combination antibiotic treatment of patients with biofilm-based chronic lung infections.
Topics
Species
